White papers & guides18 September 2025 FDA’s Draft Guidance on Overall Survival The FDA’s August 2025 draft guidance reshapes oncology clinical trials by requiring pre-specified overall survival (OS) analysis in... Learn more
Insight Briefs7 August 2025 Optimizing eCOA in Oncology Trials: Patient-Focused Data Capture for Cancer Research Oncology leads clinical innovation with 7,747 trials registered through 2022, yet only 7% of cancer patients participate. This... Learn more
Factsheets11 February 2025 Oncology factsheet Download our oncology factsheet to view an overview of our services. Learn more
Blog30 December 2024 What do we measure with PROs in head and neck cancer? Pain, QoL, adverse events and more Patient-Reported Outcomes (PROs) are essential in head and neck cancer research, offering insights into symptoms, quality of life,... Learn more
Blog22 March 2024 Measuring the true patient experience in Cancer Trials with eCOA / ePRO Shedding light on the complexities and advancements in measuring PROs, drug tolerability, and quality of life in cancer... Learn more
